Delivery Order SPE2DB20D1109-SPE2DB22FN44E

Award Date 1/18/22
Potential Completion Date 1/19/22
Potential Value $6.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,190.73, is for the delivery of Levorphanol 2 mg tablets. The contract has an ultimate completion date of July 8, 2022 and is a Firm Fixed Price Delivery Order. No set-aside designation was used. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,884.79 firm fixed-price delivery order is for the supply of 4,563,788,623 units of Levorphanol 2 mg tablets, with a performance period running through February 23, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DX22D0010|SPE2D823FCT61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,603.75 firm fixed-price delivery order is for the supply of Levorphanol Tablets 2mg, a pharmaceutical product. The contract has a completion date of January 11, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4,560,298,463 units of 2 mg Levorphanol tablets. The $7,672.84 firm fixed-price contract has a completion date of March 20, 2023. Amerisourcebergen is the child company of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA...
This federal contract award is for the delivery of 100 units of the pharmaceutical product Levorphanol 2 mg tablets. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on September 18, 2024. The contract has a ceiling value of $2,115.35 and a completion date of September 19, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,836.44, is a delivery order for 4565592573 - LEVORPHANOL 2 MG TABLET 100S. It is a firm fixed-price contract with an ultimate completion date of August 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a Delivery Order valued at $7,672.84 for the supply of Levorphanol 2 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,918.22 firm fixed-price delivery order is for the supply of 4565188701 - LEVORPHANOL 2 MG TABLET 100S. The contract has a completion date of July 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,927.24 to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,830,114 tablets of 2 mg Levorphanol, a prescription medication, by June 7, 2024. This contract is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FN44E
    Delivery Order

This federal contract award is a delivery order (SPE2DB22FN44E) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Levorphanol 2 mg tablets. The contract has a ceiling value of $6,908.53 and an ultimate completion date of January 19, 2022. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense and other federal agencies. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 11:58 AM